OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2026
(2)
2025
(1)
2024
(1)
2021
(1)
2020
(1)
2019
(1)
2017
(1)
2013
(1)
2010
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.
Not available
S-EPMC11583416
|
biostudies-literature
Cite
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study.
Not available
S-EPMC7000480
|
biostudies-literature
Cite
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).
Not available
S-EPMC12616395
|
biostudies-literature
Cite
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).
Not available
S-EPMC6924554
|
biostudies-literature
Cite
The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.
Not available
S-EPMC3852490
|
biostudies-literature
Cite
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229
|
biostudies-literature
Cite
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
Not available
S-EPMC12824789
|
biostudies-literature
Cite
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
Not available
S-EPMC12865694
|
biostudies-literature
Cite
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
Not available
S-EPMC5804835
|
biostudies-literature
Cite
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Not available
S-EPMC8078131
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets